𝔖 Bobbio Scriptorium
✦   LIBER   ✦

5-fluorouracil, 4-epidoxorubicin, and mitomycin C (FEM) for advanced gastric carcinoma. A phase II trial

✍ Scribed by W. Queißer; H. Flechtner; M. E. Heim; H. Henß; H. Arnold; D. Fritze; R. Herrmann; H. Fritsch; F. Penzkofer; F. A. Trux; K. Kabelitz; L. Edler

Book ID
112785560
Publisher
Springer-Verlag
Year
1986
Tongue
English
Weight
123 KB
Volume
111
Category
Article
ISSN
1432-1335

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase II trial of 5-fluorouracil, doxo
A phase II trial of 5-fluorouracil, doxorubicin, mitomycin C, and leucovorin in advanced gastric carcinoma
✍ Susan G. Arbuck; Yusuf Silk Md; Harold O. Douglass Jr.; Hector Nava; Youcef M. R 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 363 KB 👁 2 views

To determine the feasibility and toxicity of combining leucovorin (CF) with a 5fluorouracil(5-FU) combination chemotherapy regimen currently accepted by many as standard treatment for gastric cancer, CF (500 mg/m') was administered in combination with the Georgetown S-FU, doxorubicin, and mitomycin

A phase II study of combined 5-fluoroura
A phase II study of combined 5-fluorouracil and mitomycin C in advanced breast cancer
✍ Willy Mattsson; Finn Von Eyben; Lennart Hallsten; Göran Bjelkengren 📂 Article 📅 1982 🏛 John Wiley and Sons 🌐 English ⚖ 340 KB 👁 2 views

In a Phase I1 study, 50 patients with advanced breast cancer were treated with a combination of 5fluorouracil(lOO0 mg/m2 on days 1 and 2) and mitomycin C (6 mg/m2 on day 2) (FuMi regimen). The courses were repeated every third to sixth week. Although 35 patients had previously received combination c